Summary
This Form 8-K filing by Pfizer Inc. (PFE) on December 8, 1999, primarily serves to incorporate by reference three press releases issued in late November and early December 1999. These press releases indicate ongoing strategic activities and potential corporate actions, particularly in relation to discussions or disputes involving other pharmaceutical companies, namely Warner-Lambert Company and American Home Products. The company is actively responding to developments, including counterclaims and communications directed at shareholders of Warner-Lambert, as well as addressing filings related to American Home Products. These actions suggest a dynamic period for Pfizer, potentially involving mergers, acquisitions, or significant competitive maneuvers within the pharmaceutical industry. Investors should look to the referenced press releases for detailed information regarding the specific nature of these events and their potential impact on Pfizer's business and market position.
Key Highlights
- 1Pfizer Inc. filed an 8-K report on December 8, 1999.
- 2The report incorporates three press releases by reference, issued between November 29 and December 6, 1999.
- 3Press release dated November 29, 1999, addresses a counterclaim from Warner-Lambert Company.
- 4Press release dated December 2, 1999, responds to a letter from the Board of Directors of Warner-Lambert Company to its shareholders.
- 5Press release dated December 6, 1999, concerns a filing by American Home Products.
- 6These documents indicate active strategic and potentially contentious interactions with other major pharmaceutical entities.
- 7The filing suggests Pfizer was engaged in significant corporate developments or responses during this period.